Jan 28, 2020 / 09:30PM GMT
Operator
Greetings. Welcome to the Conatus and Histogen Joint Conference Call. (Operator Instructions) Please note this conference is being recorded.
I would now like to turn the conference over to Alan Engbring, Investor Relations Consultant for Conatus. Thank you. You may begin.
Alan R. Engbring - Conatus Pharmaceuticals Inc. - Executive Director of IR & Corporate Communications
Thank you, operator. It is my pleasure to welcome everyone to today's conference call. I'm joined by Steven J. Mento, PhD, President and Chief Executive Officer of Conatus; and Richard W. Pascoe, Chief Executive Officer and Chairman of Histogen. As a reminder, today's call will be recorded.
Additional information on the proposed transaction is available in our press release issued this afternoon. The press release and the merger agreement regarding today's announcement as well as a replay of this call will be available on Conatus' website.
We'll refer to forward-looking statements in connection with the proposed transaction and the accompanying presentation.
Conatus Pharmaceuticals Inc and Histogen Inc Enter into Definitive Merger Agreement Conference Call Transcript
Feb 13, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers